Retinoic acid and cancer treatment
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Retinoic acid which belongs to the retinoid class of chemical compounds is an important metabolite of vitamin A in diets. It is currently understood that retinoic acid plays important roles in cell development and differentiation as well as cancer treatment. Lung, prostate, breast, ovarian, bladder, oral, and skin cancers have been demonstrated to be suppressed by retinoic acid. Our results also show that low doses and high doses of retinoic acid may respectively cause cell cycle arrest and apoptosis of cancer cells. Also, the common cell cycle inhibiting protein, p27, and the new cell cycle regulator, Cdk5, are involved in retinoic acid's effects. These results provide new evidence indicating that the molecular mechanisms of/in retinoic acid may control cancer cells' fates. Since high doses of retinoic acid may lead to cytotoxicity, it is probably best utilized as a potential supplement in one's daily diet to prevent or suppress cancer progression. In this review, we have collected numerous references demonstrating the findings of retinoic acid in melanoma, hepatoma, lung cancer, breast cancer, and prostate cancer. We hope these observations will shed light on the future investigation of retinoic acid in cancer prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [342]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073 · cited 1×
“Food and Drug Administration for lymphoma [2] and leukemia [3].”
BackgroundDuvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706 · cited 1×
“Food and Drug Administration for lymphoma [2] and leukemia [3].”
BackgroundRetinoids, Retinoic Acid Receptors, and Cancer
Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596 · cited 1×
“The activation of the above classical pathway will lead to cell differentiation, arrest, and eventually apoptosis [6].”
BackgroundTseng, S. C. G., Li, D.-Q., & Ma, X. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199906)179:3<325::aid-jcp10>3.0.co;2-x · Cited by 489
Retinoid pathway and cancer therapeutics
Bushue, N., & Wan, Y.-J. Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.003 · Cited by 373 · cited 1×
“To turn on downstream gene expression, RAR and RXR shuttle into cell nuclei and bind to the retinoic acid response elements (RARE), which are located in the 5’-region of retinoic acid downstream genes [5].”
BackgroundGenomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer
Hua, S., Kittler, R., & White, K. P. (2009) · Cell · doi:10.1016/j.cell.2009.04.043 · Cited by 307 · cited 1×
“elucidated the genomic antagonism between retinoic acid and estrogen signaling in breast cancer and published their findings in the journal, Cell [55].”
BackgroundConnolly, R. M., Nguyen, N. K., & Sukumar, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3175 · Cited by 211
Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
Ying, M., Wang, S., Sang, Y., Sun, P., Lal, B., Goodwin, C. R., Guerrero-Cazares, H., Quinones-Hinojosa, A., Laterra, J., & Xia, S. (2011) · Oncogene · doi:10.1038/onc.2011.58 · Cited by 204
Lotan, R. (1979) · PubMed · Cited by 187
Marcato, P., Dean, C. A., Liu, R., Coyle, K. M., Bydoun, M., Wallace, M., Clements, D. R., Turner, C., Mathenge, E. G., Gujar, S. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.010 · Cited by 152 · cited 1×
“Aldehyde dehydrogenase 1A3 (ALDH1A3) influences breast cancer progression via differential retinoic acid signaling [43].”
Background
Research works printed but not linked: 1
- Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, Paroni G, et al. Induction of miR-21 by retinoic acid in estrogen receptorpositive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem 2011; 286: 4027–42. · DOI
Cited by
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis
Dhiman, V. K., Bolt, M. J., & White, K. P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.102 · Cited by 121
New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene
Puah, B.-P., Jalil, J., Attiq, A., & Kamisah, Y. (2021) · Molecules · doi:10.3390/molecules26133888 · Cited by 106
“The attenuation of RAR expression by retinoic acid was considered abnormal as retinoic acid was known for its anti-cancer activity via activation of RAR or RXR [134].”
BackgroundChang, J., Zhong, R., Tian, J.-B., Li, J.-Y., Zhai, K., Ke, J., Lou, J., Chen, W., Zhu, B.-B., Shen, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0045-8 · Cited by 88
Epigenetic modifications in prostate cancer
Sugiura, M., Sato, H., Kanesaka, M., Imamura, Y., Sakamoto, S., Ichikawa, T., & Kaneda, A. (2020) · International Journal of Urology · doi:10.1111/iju.14406 · Cited by 88
Metadata
- Authors
- Chen, M.-C., Hsu, S.-L., Lin, H., & Yang, T.-Y.
- Affiliations
- Taichung Veterans General Hospital (TW)
- National Chung Hsing University (TW)
- Corresponding author
- Lin, Ho
- Yang, Tsung-Ying
- Venue
- BioMedicine
- Publisher
- China Medical University
- Published
- 2014-11-28
- Volume
- 4
- Issue
- 4
- Pages
- 22-22
- ISSN
- 2211-8020 (ISSN-L)
- 2211-8039
- PMC
- PMC4265016
- OpenAlex
- W2139840459
- Cited by
- 105
- References
- 86
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 16 · 2018: 6 · 2017: 13 · 2016: 5 · 2015: 1
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Biomedicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- retinoic acid, retinoids, vitamin A metabolites, chemoprevention, cancer therapy, cell cycle arrest, apoptosis, p27, cyclin-dependent kinase 5, melanoma, hepatocellular carcinoma, lung cancer, breast cancer, prostate cancer, dietary supplementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoic acid and cancer treatment. https://app.cochat.ai/papers/10.7603/s40681-014-0022-1
- The paper
- Chen, M.-C., Hsu, S.-L., Lin, H., & Yang, T.-Y. (2014). Retinoic acid and cancer treatment. BioMedicine. https://doi.org/10.7603/s40681-014-0022-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.